Allergan to begin phase 3 trials of Medytox’s ‘Innotox’ in US, Canada this week
IndustryOct 29, 2018
Allergan will formally begin phase 3 clinical trials of Medytox’s Type A liquid-type botulinum toxin this week, as recruitment for the clinical study is slated to start Wednesday, according to data shown on ClinicalTrials.gov.Allergan recently posted its clinical trial agenda for MT10109L on ClinicalTrials.gov. The third-phase clinical study aims to evaluate the safety and efficacy of the drug for the treatment of moderate to severe glabellar and lateral canthal lines, the firm said, referring t